Putting the colours into chromogenic in situ hybridization (CISH)

Journal of Pathology

Volumn 210, Issue 1, 2006, Pages 1-2

  Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chromogenic; Diagnosis; In situ hybridization; Tumour

Indexed keywords

CHROMOGENIC SUBSTRATE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; PARAFFIN;

BREAST CANCER; BRIGHT FIELD MICROSCOPY; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; DRUG TARGETING; DUAL COLOR CHROMOGENIC IN SITU HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; MEDICAL RESEARCH; MOLECULAR PROBE; MUTATIONAL ANALYSIS; NOTE; ONCOGENE NEU; PRIORITY JOURNAL; TISSUE MICROARRAY; VALIDATION PROCESS;

COLOR; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION; NEOPLASMS;

EID: 33747889947     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2036     Document Type: Note

References (11)

1. Bown N. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 2001;54:897-910.
2. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-792.
3. Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 2005;6:782-792.
4. Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi OP, Isola JJ. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994;16:93-99.
5. Lu YJ, Birdsall S, Summersgill B, Smedley D, Osin P, Fisher C, et al. Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18) (p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma. J Pathol 1999;187:490-496.
6. Shipley J, Fisher C. Chromosome translocations in sarcomas and the analysis of paraffin-embedded material. J Pathol 1998;184:1-3.
7. Tanner M, Ganeberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, et al. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000;157:1467-1472.
8. Laakso M, Tanner M, Isola J. Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours. J Pathol 2006;210:3-9.
9. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-847.
10. Wang G, Brennan C, Rook M, Wolfe JL, Leo C, Chin L, et al. Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res 2004;32:e76.
11. Le Caignec C, Spits C, Sermon K, De Rycke M, Thienpont B, Debrock S, et al. Single-cell chromosomal imbalances detection by array CGH. Nucleic Acids Res 2006;34:e68.